Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma

Affiliations

• ¹ Medical Director, Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center; Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; Consultant, The Head and Neck Institute, Portland, OR. Electronic address: richard.bell@providence.org.
• ² Co-Director, Providence Oral, Head and Neck Cancer Program, Providence Cancer Center; Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.
• ³ Predoctoral student, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; MD/PhD Program, Oregon Health and Science University, Portland, OR.
• ⁴ Director of Translational Radiation Research, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center; Radiation Oncologist, Providence Oral, Head and Neck Cancer Program and Clinic, Providence Cancer Center, Portland, OR.
• ⁵ Member and Investigator, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.
• ⁶ Chief, Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.